Overview

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2031-03-01

Target enrollment:

Participant gender:

Summary

LESLIE is a multicentric randomized controlled trial in patients with triple negative breast cancer receiving neoadjuvant chemo/immunotherapy (NAT). This trial investigates the hypothesis that adding a cyclic fasting-mimicking diet combined with exercise during the NAT improves the NAT's therapeutic efficacy, treatment tolerability and compliance, as well as improve quality of life.

Phase:

PHASE2

Details

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Collaborators:

AZ Groeninge
Institute Gustave Roussy Paris
Jessa Ziekenhuis Hasselt
KU Leuven
Universitair Ziekenhuis Brussel
UZ Antwerpen
UZ Gent, Belgium
Ziekenhuis ad Stroom, Antwerpen

Treatments:

Exercise Therapy